T1	Participants 64 122	patients with mild-to-moderately-active ulcerative colitis
T2	Participants 465 676	patients with symptoms of acute UC and a baseline Modified Mayo Disease Activity Index (MMDAI) score between 6 and 10, inclusive, with a subscale rating of > or =2 for both rectal bleeding and mucosal appearance
